B

Best Quality Research,Inc. | Hialeah, FL

Research site

(Unclaimed)

Location

2387 W 68TH ST, 403, HIALEAH, Florida, United States of America

Site insights

Top conditions

Top treatments

Allopurinol

Vibegron

Oseltamivir

GS-1427

Ribavirin

Tolterodine

JNJ-53718678

ALLN-346

Obeldesivir

Bococizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 24 total trials

A Study of Dotinurad Versus Allopurinol in Participants With Gout

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol i...

Enrolling

Gout

Drug: Allopurinol

Drug: Dotinurad

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol i...

Enrolling

Tophaceous Gout

Drug: Allopurinol

Drug: Dotinurad

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting

Cytomegalovirus Infection

Biological: mRNA-1647

Biological: Placebo

A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis (Nova 301)

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prev...

Active, not recruiting

Acute Gastroenteritis

Norovirus Acute Gastroenteritis

Biological: mRNA-1403

Biological: Placebo

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (SWIFT)

The goal of this study is to learn if GS-1427 is effective in treating participants with moderate to severe ulcerative colitis. The study will compar...

Enrolling

Ulcerative Colitis

Drug: GS-1427

Drug: Placebo-to-match GS-1427